Indivior shares soar on earnings beat and strong growth outlook
Full year sales and profit up 21% and 27% respectivelyPlans for primary US listing2024 outlook above consensus estimatesShares in Indivior (INDV) surged 18% to top the FTSE mid-cap index after the Opioid-use disorder treatment...
22 February 2024
